Managing kidney disease with blood-pressure control. - Wikidata - awgldk - TriplyDB

Managing kidney disease with blood-pressure control.

Managing kidney disease with blood-pressure control.

http://www.wikidata.org/entity/Q37892340

about

Antihypertensive agents for children with chronic kidney disease Antihypertensive agents for children with chronic kidney disease Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes Reduced incidence of end stage renal disease among the elderly in Denmark: an observational study.Relationship between prehypertension and chronic kidney disease in middle-aged people in Korea: the Korean genome and epidemiology study.Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.Chronic kidney disease: highlights for the general pediatrician.Impaired renal function and development in Belgrade rats.Strategies for the preservation of residual renal function in pediatric dialysis patients.Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.Determinants of decline of renal function in treated hypertensive patients: the Campania Salute Network.The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.Persistent and inducible neogenesis repopulates progenitor renin lineage cells in the kidney.Increased urinary angiotensinogen is an effective marker of chronic renal impairment in very low birth weight children.Approach to cardiovascular disease prevention in patients with chronic kidney disease.

P2860

Q24186875-F17E3353-2CFA-4DAD-B3F8-288F9CD7A104 Q24201336-0A3E595E-5965-4726-A726-6E0889DD98A7 Q34416954-8C71C736-55A4-44E0-BB23-0A0CDC017696 Q34433011-3BBC1DD6-8A3C-4F63-9507-B540F30E349B Q34471215-0D0C9971-8DE5-4AA2-BF2F-038557CCA3EB Q35917508-931B49AC-38DB-465A-AFA8-308E02F8D1B9 Q36100052-89F4A9A1-515E-42CE-8067-1BC268F4E77E Q37575558-D37C449D-2019-48C5-9257-C292E1826E75 Q38122625-79E61CD2-C7ED-4578-A1B1-4CB27A441179 Q38527010-11D96C3D-4016-47B0-A47D-88B8F57DE869 Q40203629-249FBCD3-9EB8-46BE-907E-77A41297E9FC Q44462069-7BBA7F97-E307-49B5-A7DE-C9B3C2823705 Q45062891-2F34F8A8-EA64-41B8-A36E-D536AA4A7CF1 Q46735321-BE528F1E-502A-4B05-9870-D650F54690EF Q49136022-573A3E0E-4642-446F-A2A0-9C2054A429A1

P2860

Managing kidney disease with blood-pressure control.

http://www.wikidata.org/entity/Q37892340

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Managing kidney disease with blood-pressure control.

@en

Managing kidney disease with blood-pressure control.

@nl

type

label

Managing kidney disease with blood-pressure control.

@en

Managing kidney disease with blood-pressure control.

@nl

prefLabel

Managing kidney disease with blood-pressure control.

@en

Managing kidney disease with blood-pressure control.

@nl

P1433

Q37892340-B43348D1-C992-467E-8BE1-092BB4D0C523

P1476

Q37892340-1FE71058-59C7-47BF-9D8B-9E362C35DEAB

P2093

Q37892340-74FEE5F9-901D-402A-84C0-365590D4C9CC

Q37892340-A88EE4A4-6D1E-48AD-B244-62A4C70C56A9

P2860

Q37892340-0DB73D3F-77CC-4A09-BF1C-8D2D0AF4A7F3

Q37892340-10900591-2501-4624-9601-2AFA8BCB683A

Q37892340-116EE10B-9031-492C-8F97-F554E1C90D55

Q37892340-16F98245-994E-4C30-B818-9416C41A7E3C

Q37892340-172FACE9-F674-42E2-8ED3-DACEF754B01A

Q37892340-18931307-80CD-48FA-B440-B83141BD7FAE

Q37892340-24E4EDDF-6C04-468B-B469-FA956946E4B4

Q37892340-2594E846-21A3-4CC8-95BF-B5564BDFED0D

Q37892340-26BC4227-49A6-4EA6-94E4-CCA7E5A33A3D

Q37892340-2AD72FA8-EE43-4D14-884E-7CDFD1AAD758

P2888

Q37892340-B2AE9428-9595-4905-8085-8F0A57E004F4

P304

Q37892340-83A24E56-AD7B-4322-B735-EFABFEA7F8A7

P31

Q37892340-58AB64EB-909B-4C2A-8489-B5A033E5D133

P356

Q37892340-7F042326-F01A-4079-9ECD-02386BE97D6A

P407

Q37892340-6A186F7A-DD4F-41E1-9078-038F47856EC6

P433

Q37892340-A45AAB3F-801B-4C08-BCD7-4232DA48EEAF

P478

Q37892340-2DEB9387-5B46-4B2E-A254-22E57F0577E6

P577

Q37892340-FB198358-521D-4463-9BAC-2FE5C4D4538E

P698

Q37892340-C731D1F9-357C-4625-9299-7DBF3E5DC9C8

P356

P1433

Nature Reviews Nephrology

P1476

Managing kidney disease with blood-pressure control.

@en

P2093

Elke Wühl

http://www.w3.org/2001/XMLSchema#string

Franz Schaefer

http://www.w3.org/2001/XMLSchema#string

P2860

Supramaximal dose of candesartan in proteinuric renal disease

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Epidemiology of chronic renal failure in children: data from the ItalKid project.

Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus.

Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project.

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

P2888

P304

434-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2011.73

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21691318

http://www.w3.org/2001/XMLSchema#string